ENvue Medical Study Shows 67% Drop in VAP Cases, $1.5M in Year-One Savings — ENvue Medical, Inc.

Event summary

Independent study in Critical Care Nurse journal showed ENvue’s platform reduced ventilator-associated pneumonia (VAP) cases by 67% at Inova Health System.
First-year deployment saved over 350 nursing hours and cut repeat imaging by 20%, avoiding $1.5M in costs.
Study covered 531 consecutive feeding tube placements across five hospitals with no added clinical staffing.
Clinicians reported high usability and near-unanimous recommendation for the platform.
ENvue’s technology eliminated accidental lung insertions in all cases studied.

The big picture

This study validates ENvue’s platform as a disruptive force in ICU care, addressing a long-standing procedural risk with measurable efficiency gains. The findings position ENvue to challenge traditional feeding tube placement methods, particularly as hospitals face increasing pressure to reduce complications and operational costs. The scale of potential impact—$1.5M in first-year savings at a single health system—suggests significant upside if adoption expands beyond early adopters.

What we're watching

Adoption Pace: Whether ENvue can sustain this commercial momentum across broader hospital networks.
Competitive Response: How existing blind-placement methods will adapt to this validated alternative.
Regulatory Tailwinds: The extent to which AHRQ benchmarks may accelerate platform integration as standard care.